These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34372589)

  • 21. Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells.
    Cong Y; McArthur MA; Cohen M; Jahrling PB; Janosko KB; Josleyn N; Kang K; Zhang T; Holbrook MR
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004709. PubMed ID: 27191161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.
    Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD
    Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Completed sequences analysis on the Chinese attenuated yellow fever 17D vaccine strain and the WHO standard yellow fever 17D vaccine strain].
    Li J; Yu YX; Dong GM
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):145-51. PubMed ID: 20077661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism.
    Wang HJ; Guo Y; He MJ; Liu ZY; Ye Q; Huang XY; Deng YQ; Li XF; Qin CF
    Microbiol Spectr; 2022 Oct; 10(5):e0224622. PubMed ID: 35980184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.
    Hahn CS; Dalrymple JM; Strauss JH; Rice CM
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2019-23. PubMed ID: 3470774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Diversity Does Not Contribute to Attenuation of HeLa Passaged Wild-Type Yellow Fever Virus Strain French Viscerotropic Virus.
    Strother AE; Thompson JK; Widen SG; Barrett ADT
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein.
    Bonaldo MC; Garratt RC; Freire MS; Galler R
    Cell Biochem Biophys; 2006; 44(3):313-24. PubMed ID: 16679518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing.
    Pugachev KV; Ocran SW; Guirakhoo F; Furby D; Monath TP
    Vaccine; 2002 Jan; 20(7-8):996-9. PubMed ID: 11803058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
    Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
    J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it.
    Jennings AD; Whitby JE; Minor PD; Barrett AD
    Virology; 1993 Feb; 192(2):692-5. PubMed ID: 8421909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type Asibi parent virus.
    Cammack N; Gould EA
    Virology; 1986 Apr; 150(2):333-41. PubMed ID: 2421479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.
    Gould EA; Buckley A; Cane PA; Higgs S; Cammack N
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoblotting reveals differences in the accumulation of envelope protein by wild-type and vaccine strains of yellow fever virus.
    Cane PA; Gould EA
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():557-64. PubMed ID: 2732701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2'-O-methyltransferase-deficient yellow fever virus: Restricted replication in the midgut and secondary tissues of Aedes aegypti mosquitoes severely limits dissemination.
    Vom Hemdt A; Thienel AL; Ciupka K; Wieseler J; Proksch HM; Schlee M; Kümmerer BM
    PLoS Pathog; 2024 Oct; 20(10):e1012607. PubMed ID: 39356716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.
    Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J
    Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.
    Bassi MR; Larsen MA; Kongsgaard M; Rasmussen M; Buus S; Stryhn A; Thomsen AR; Christensen JP
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004464. PubMed ID: 26886513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes.
    McGee CE; Tsetsarkin K; Vanlandingham DL; McElroy KL; Lang J; Guy B; Decelle T; Higgs S
    J Infect Dis; 2008 Mar; 197(5):686-92. PubMed ID: 18266608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenesis analysis of T380R mutation in the envelope protein of yellow fever virus.
    Huang YJ; Nuckols JT; Horne KM; Vanlandingham D; Lobigs M; Higgs S
    Virol J; 2014 Mar; 11():60. PubMed ID: 24678844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of a hamster viscerotropic strain of yellow fever virus.
    McArthur MA; Suderman MT; Mutebi JP; Xiao SY; Barrett AD
    J Virol; 2003 Jan; 77(2):1462-8. PubMed ID: 12502861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.